High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation

C Shimazaki; R Uchida; S Nakano; K Namura; S-i Fuchida; A Okano; M Okamoto; T Inaba

首页> 外文期刊>Leukemia >High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation

【24h】

High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation

机译：硼替佐米联合治疗难治性多发性骨髓瘤后高血清骨特异性碱性磷酸酶水平：硼替佐米对成骨细胞分化的可能作用

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Leukemia》 |2005年第6期|共2页
作者
C Shimazaki; R Uchida; S Nakano; K Namura; S-i Fuchida; A Okano; M Okamoto; T Inaba;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options [J] . Güven ?etin, Ahmet Emre E?kazan, M. Cem Ar, Turkish Journal of Hematology . 2014,第4期

机译：接受多种治疗方案的多发性骨髓瘤患者的骨特异性碱性磷酸酶水平
2. Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysis. [J] . Lund T, Abildgaard N, Andersen TL, European Journal of Haematology . 2010,第5期

机译：多发性骨髓瘤：I型胶原的血清C末端端肽和骨特异性碱性磷酸酶的变化可用于日常实践中，以检测即将发生的骨溶解。
3. 2104 POSTER Serum Levels of N-telopeptide (sNTX) and bone-specific alkaline phosphatase (BAP) in oncology patients (pts) who developed osteonecrosis of the jaw (ONJ) during therapy with intravenous bisphosphonates (IB) [J] . M.Fornier, A.Farooki, C.Estilo, European Journal of Cancer Supplements . 2007,第4期

机译：2104在静脉内双膦酸盐（IB）治疗期间发生颌骨坏死（ONJ）的肿瘤患者（pts）中血清N-端肽（sNTX）和骨特异性碱性磷酸酶（BAP）的血清水平
4. A Phase 1/2 Study of Ixazomib as a Replacement for Bortezomib or Carfilzomib for Multiple Myeloma Patients Recently Relapsed or Refractory to Their Last Combination Regimen Containing Either Bortezomib or Carfilzomib [D] . Forouzan, Eli. 2020

机译：Ixazomib的第1/2期作为替代品髓鞘或胭脂瘤患者的替代品的替代物，最近对含有Bortezomib或Carfilzomib的最后组合方案复发或难治
5. Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options [O] . Güven Çetin, Ahmet Emre Eşkazan, M. Cem Ar, 2014

机译：多发性骨髓瘤患者接受各种治疗方案后的骨特异性碱性磷酸酶水平
6. Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options [O] . Güven Çetin, Ahmet Emre Eşkazan, M. Cem Ar, 2014

机译：接受多种治疗方案的多发性骨髓瘤患者骨特异性碱性磷酸酶水平

High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation

著录项

相似文献

相关主题

期刊订阅